北京凡知医学科技有限公司
BEIJING FIREGEN BIOMEDICALS CO., LTD.
北京凡知医学科技有限公司是一家全球化运营的生物医药企业，由资深的中科院科学家、海归科学家、临床专家创立，坚持自主研发，实现“核酸、芯片、机械、软件”四大底层技术从进口替代到全球创新转变，为社会提供“仪器、芯片、诊断试剂、互联网远程诊疗”产品及服务，助推先进核酸诊断技术进入基层医疗体系，惠及普通大众，打造国际先进的重大疾病快速诊疗品牌。
总部坐落于北京市海淀区，在北京、天津、上海、江苏、河南、美国等多地设有大型GMP厂房、研发中心和医学检验所。作为国家级“高新技术企业”、“专精特新企业”和“中国科创企业百强”，凡知医学致力于科技与市场的“双轮驱动”，目前已获得国内外专利200余项，数十款产品获得中国NMPA、欧盟CE和美国FDA资质，客户遍及全球30多个国家和地区，并获得多家政府基金和知名社会资本的青睐，完成7轮以上融资，驶入生物医药创新发展和国际化的快车道。 BEIJING FIREGEN BIOMEDICALS CO., LTD.
Beijing FireGen Biomedicals Co., Ltd. is a globally operated biopharmaceutical enterprise founded by senior scientists from the Chinese Academy of Sciences, returned overseas scientists, and clinical experts. It adheres to independent research and development, achieving the transformation from import substitution to global innovation in four underlying technologies: Nucleic Acids, Chips, Machinery, and Software. The company provides products and services including instruments, chips, diagnostic reagents, and internet-based remote diagnosis, promoting the advanced technology of nucleic acid-based diagnosis into grassroots medical systems, benefiting the general public, and creating an internationally advanced brand for rapid diagnosis and treatment of serious illnesses.
Headquartered in Haidian District, Beijing, FireGen Biomedicals has large GMP factories, research centers, and medical laboratories in Beijing, Tianjin, Shanghai, Jiangsu, Henan, the United States, and other locations. As a national-level “High-Tech Enterprise”, “Specialized and Sophisticated Enterprises”, and one of “China’s Top 100 Innovative Enterprises”, FireGen Biomedicals is committed to the “dual-drive” of technology and market. We have obtained over 150 domestic and foreign patents, and dozens of products have obtained qualifications from NMPA (National Medical Products Administration, P.R.C.), CE (EU), and FDA (Food and Drug Administration, U.S.). Our customers span over 30 countries and regions worldwide and we have garnered favor from numerous government funds and well-known social capital. With over 7 rounds of financing completed, FireGen is accelerating towards innovation and internationalization in biopharmaceutical development.